Medlab Efficacy Magazine

Medlab's New Efficacy Magazine

A true integrative approach to medicine and health

Issue 2: December 2016 - February 2017

A year in review: Research Update

Medlab’s quartely magazine designed to educate and update Practitioners with Medlab research and industry advancements with a variety of contributing authors. Register or log in to view today.

NanoCelle D3 + K2 Featured product

New - NanoCelle D3 + K2

NanoCelle™ D3 + K2 is developed from patent-protected nanocellization technology that produces Vitamin D3 and Vitamin K2 submicron nanoparticles that are easily absorbed across the oral mucosal epithelia. NanoCelle™ D3 + K2 is indicated to sustain mineral homeostasis facilitating optimal immune function, cardiovascular health and bone metabolism, and to assist in the management of medically diagnosed vitamin D deficiency.

More Information

Immune-5 product

New - Immune-5™ Vanilla or Raspberry

Immune-5™ is a scientifically-based comprehensive formula containing two specific probiotic species shown to assist with immune function and may assist with upper respiratory tract infections. ResistAid™ is a prebiotic soluble fibre while Lactoferrin is a naturally occurring protein found in the body with broad spectrum anti-microbial and anti-viral activity. Colostrum provides important innate immune supporting proteins including the antibody IgG that both activates and modulates the body defence processes.

More Information


Academy of Science, Frontiers of Science


When: Tuesday 29th Nov - Thursday 1st Dec 2016
Where: Mercure Grosvenor Hotel, 125 North Terrace, South Australia
Professor Luis Vitetta & Talia Palacios


Congratulations to the Medlab team! Best early-phase chronic disease drug discovery company. Click the link to review the article, featured on pages 16 and 17.

Best Early-Phase Chronic Disease Drug Discovery Company Award

Medlab's research featured on Channel 9 news

Medlab Clinical is at the forefront of research into obesity and the prevention of diabetes. Medlab's probiotic formulation is currently undergoing clinical trial evaluation in collaboration with the University of Sydney's Boden Institute as featured in a recent Channel 9 news item.

Watch Interview